In vitro bioactivity profile-driven discovery of drug synergies in hepatocellular carcinoma
Tuan Xu(University of Chinese Academy of Sciences), Ruili Huang(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Deborah K. Ngan(National Institutes of Health), Tongan Zhao(National Center for Advancing Translational Sciences), Miao Xu(National Institutes of Health), Wei Zheng(National Institutes of Health)
Cited by 0
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
|Cell Discovery|2018|194
RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
|SLAS DISCOVERY|2020|192